TCR2 Therapeutics (TCRR) PT Lowered to $38 at BMO Capital, Following Strategic Business Update Oct 20, 2021 04:29PM
TCR2 Therapeutics (TCRR) ESMO Data Presents a Buying Opportunity - BMO Capital Sep 20, 2021 07:22AM
TCR2 Therapeutics (TCRR) PT Lowered to $44 at BMO Capital, Following Earnings Aug 5, 2021 04:48PM
TCR2 Therapeutics (TCRR) PT Lowered to $53 at BMO Capital May 13, 2021 12:49PM
TCR2 Therapeutics (TCRR) PT Lowered to $56 at BMO Capital Mar 11, 2021 12:47PM


Jan 20, 2021 06:20AM TCR2 Therapeutics (TCRR) Prices 4.59M Share Common Offering at $30.50/Sh
Jan 19, 2021 10:02PM TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock
Jan 19, 2021 10:02PM TCR² Therapeutics Announces Pricing of Public Offering of $140.0 Million of Common Stock
Jan 19, 2021 06:28AM TCR2 Therapeutics (TCRR) Announces $125M Proposed Public Offering of Common Stock
Jan 19, 2021 06:24AM TCR² Therapeutics Announces Proposed Public Offering of Common Stock
Jan 19, 2021 06:24AM TCR² Therapeutics Announces Proposed Public Offering of Common Stock
Jul 29, 2020 05:47AM TCR2 Therapeutics (TCRR) Prices 8M Share Common Offering at $15.50/Sh
Jul 28, 2020 08:06PM TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
Jul 28, 2020 08:05PM TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
Jul 27, 2020 04:01PM TCR2 Therapeutics (TCRR) to Offer 6M Common Shares
Jul 27, 2020 04:01PM TCR² Therapeutics Announces Proposed Public Offering of Common Stock
Jul 27, 2020 04:01PM TCR² Therapeutics Announces Proposed Public Offering of Common Stock
Jul 27, 2020 07:57AM TCR2 Therapeutics (TCRR) PT Raised to $45 at BMO Capital
Nov 12, 2019 10:49AM TCR2 Therapeutics (TCRR) PT Lowered to $35 at BMO Capital
Mar 11, 2019 01:29AM BMO Capital Starts TCR2 Therapeutics (TCRR) at Outperform
Feb 26, 2019 04:30PM TCR2 Therapeutics Announces Exercise of Over-Allotment Option
Feb 14, 2019 11:12AM TCR2 Therapeutics (TCRR) IPO Opens Flat
Feb 14, 2019 05:48AM TCR2 Therapeutics Inc. (TCRR) Prices 5M Share IPO at $15/Sh
Feb 13, 2019 08:33PM TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock
Feb 1, 2019 03:42PM TCR2 Therapeutics Inc. (TCRR) Announces Proposed 5M Share IPO Between $14-$16/Sh
Feb 1, 2019 03:34PM TCR2 Therapeutics Launches Proposed Initial Public Offering